Health

FDA bans Juul e-cigarette products

The Food and Drug Administration has ordered Juul Labs Inc. to stop selling its vaping products in the U.S., saying the products could be unsafe.

FDA approves marketing for new Alzheimer's early detection test

The Lumipulse G β-Amyloid Ratio (1-42/1-40) test is available at clinical laboratories nationwide for adult patients aged 55 years and older who are presenting with cognitive impairment and being evaluated for Alzheimer’s disease and other causes of cognitive decline.